dronabinol has been researched along with phentermine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Addy, C; Chakraborty, B; Chen, N; Chodakewitz, J; Dunbar, S; Maes, A; Rosko, K; Schoedel, KA; Sellers, EM; Stoch, SA; Wagner, J | 1 |
1 review(s) available for dronabinol and phentermine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dronabinol and phentermine
| Article | Year |
|---|---|
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users.
Topics: Adult; Amides; Behavior, Addictive; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Inverse Agonism; Drug Users; Female; Humans; Male; Marijuana Abuse; Middle Aged; Neuropsychological Tests; Phentermine; Psychomotor Performance; Pulse; Pyridines; Receptor, Cannabinoid, CB1 | 2012 |